Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)#
Abstract. Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients. The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on vitiligo in the past 3 years in combination with the clinical experience...
Ausführliche Beschreibung
Autor*in: |
Tie-Chi Lei [verfasserIn] Ai-E Xu [verfasserIn] Tian-Wen Gao [verfasserIn] Li He [verfasserIn] Hua Gu [verfasserIn] Ming Li [verfasserIn] Tie-Nan Li [verfasserIn] Chun-Ying Li [verfasserIn] Tong Lin [verfasserIn] Kuan-Hou Mu [verfasserIn] Chai-Xia Tu [verfasserIn] Hai Wen [verfasserIn] Ji-Yuan Wu [verfasserIn] Jun-Ling Zhang [verfasserIn] Zhi-Zhong Zhen [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2021 |
---|
Übergeordnetes Werk: |
In: International Journal of Dermatology and Venerology - Wolters Kluwer Health, 2020, 4(2021), 1, Seite 10-15 |
---|---|
Übergeordnetes Werk: |
volume:4 ; year:2021 ; number:1 ; pages:10-15 |
Links: |
Link aufrufen |
---|
DOI / URN: |
10.1097/JD9.0000000000000151 |
---|
Katalog-ID: |
DOAJ072984511 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ072984511 | ||
003 | DE-627 | ||
005 | 20230309112723.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/JD9.0000000000000151 |2 doi | |
035 | |a (DE-627)DOAJ072984511 | ||
035 | |a (DE-599)DOAJ91e0e1767fea40b0ab30a0b7032d7d00 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RL1-803 | |
100 | 0 | |a The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine |e verfasserin |4 aut | |
245 | 1 | 0 | |a Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)# |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract. Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients. The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on vitiligo in the past 3 years in combination with the clinical experiences of experts. The newly revised points include maintenance therapy, early glucocorticoid intervention, and oral mini-pulsed glucocorticoid administration protocols. The prospect of using JAK inhibitors in the treatment of vitiligo is also discussed. | ||
653 | 0 | |a Dermatology | |
700 | 0 | |a Tie-Chi Lei |e verfasserin |4 aut | |
700 | 0 | |a Ai-E Xu |e verfasserin |4 aut | |
700 | 0 | |a Tian-Wen Gao |e verfasserin |4 aut | |
700 | 0 | |a Li He |e verfasserin |4 aut | |
700 | 0 | |a Hua Gu |e verfasserin |4 aut | |
700 | 0 | |a Ming Li |e verfasserin |4 aut | |
700 | 0 | |a Tie-Nan Li |e verfasserin |4 aut | |
700 | 0 | |a Chun-Ying Li |e verfasserin |4 aut | |
700 | 0 | |a Tong Lin |e verfasserin |4 aut | |
700 | 0 | |a Kuan-Hou Mu |e verfasserin |4 aut | |
700 | 0 | |a Chai-Xia Tu |e verfasserin |4 aut | |
700 | 0 | |a Hai Wen |e verfasserin |4 aut | |
700 | 0 | |a Ji-Yuan Wu |e verfasserin |4 aut | |
700 | 0 | |a Jun-Ling Zhang |e verfasserin |4 aut | |
700 | 0 | |a Zhi-Zhong Zhen |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t International Journal of Dermatology and Venerology |d Wolters Kluwer Health, 2020 |g 4(2021), 1, Seite 10-15 |w (DE-627)1738992934 |x 26418746 |7 nnns |
773 | 1 | 8 | |g volume:4 |g year:2021 |g number:1 |g pages:10-15 |
856 | 4 | 0 | |u https://doi.org/10.1097/JD9.0000000000000151 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/91e0e1767fea40b0ab30a0b7032d7d00 |z kostenfrei |
856 | 4 | 0 | |u http://journals.lww.com/10.1097/JD9.0000000000000151 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2096-5540 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2641-8746 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
951 | |a AR | ||
952 | |d 4 |j 2021 |e 1 |h 10-15 |
author_variant |
v e g o t d p c c s o i c a w m t vegotdpccsoicawm vegotdpccsoicawmt t c l tcl a e x aex t w g twg l h lh h g hg m l ml t n l tnl c y l cyl t l tl k h m khm c x t cxt h w hw j y w jyw j l z jlz z z z zzz |
---|---|
matchkey_str |
article:26418746:2021----::osnuoteigoiadramnovtlgic |
hierarchy_sort_str |
2021 |
callnumber-subject-code |
RL |
publishDate |
2021 |
allfields |
10.1097/JD9.0000000000000151 doi (DE-627)DOAJ072984511 (DE-599)DOAJ91e0e1767fea40b0ab30a0b7032d7d00 DE-627 ger DE-627 rakwb eng RL1-803 The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine verfasserin aut Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)# 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract. Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients. The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on vitiligo in the past 3 years in combination with the clinical experiences of experts. The newly revised points include maintenance therapy, early glucocorticoid intervention, and oral mini-pulsed glucocorticoid administration protocols. The prospect of using JAK inhibitors in the treatment of vitiligo is also discussed. Dermatology Tie-Chi Lei verfasserin aut Ai-E Xu verfasserin aut Tian-Wen Gao verfasserin aut Li He verfasserin aut Hua Gu verfasserin aut Ming Li verfasserin aut Tie-Nan Li verfasserin aut Chun-Ying Li verfasserin aut Tong Lin verfasserin aut Kuan-Hou Mu verfasserin aut Chai-Xia Tu verfasserin aut Hai Wen verfasserin aut Ji-Yuan Wu verfasserin aut Jun-Ling Zhang verfasserin aut Zhi-Zhong Zhen verfasserin aut In International Journal of Dermatology and Venerology Wolters Kluwer Health, 2020 4(2021), 1, Seite 10-15 (DE-627)1738992934 26418746 nnns volume:4 year:2021 number:1 pages:10-15 https://doi.org/10.1097/JD9.0000000000000151 kostenfrei https://doaj.org/article/91e0e1767fea40b0ab30a0b7032d7d00 kostenfrei http://journals.lww.com/10.1097/JD9.0000000000000151 kostenfrei https://doaj.org/toc/2096-5540 Journal toc kostenfrei https://doaj.org/toc/2641-8746 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 AR 4 2021 1 10-15 |
spelling |
10.1097/JD9.0000000000000151 doi (DE-627)DOAJ072984511 (DE-599)DOAJ91e0e1767fea40b0ab30a0b7032d7d00 DE-627 ger DE-627 rakwb eng RL1-803 The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine verfasserin aut Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)# 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract. Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients. The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on vitiligo in the past 3 years in combination with the clinical experiences of experts. The newly revised points include maintenance therapy, early glucocorticoid intervention, and oral mini-pulsed glucocorticoid administration protocols. The prospect of using JAK inhibitors in the treatment of vitiligo is also discussed. Dermatology Tie-Chi Lei verfasserin aut Ai-E Xu verfasserin aut Tian-Wen Gao verfasserin aut Li He verfasserin aut Hua Gu verfasserin aut Ming Li verfasserin aut Tie-Nan Li verfasserin aut Chun-Ying Li verfasserin aut Tong Lin verfasserin aut Kuan-Hou Mu verfasserin aut Chai-Xia Tu verfasserin aut Hai Wen verfasserin aut Ji-Yuan Wu verfasserin aut Jun-Ling Zhang verfasserin aut Zhi-Zhong Zhen verfasserin aut In International Journal of Dermatology and Venerology Wolters Kluwer Health, 2020 4(2021), 1, Seite 10-15 (DE-627)1738992934 26418746 nnns volume:4 year:2021 number:1 pages:10-15 https://doi.org/10.1097/JD9.0000000000000151 kostenfrei https://doaj.org/article/91e0e1767fea40b0ab30a0b7032d7d00 kostenfrei http://journals.lww.com/10.1097/JD9.0000000000000151 kostenfrei https://doaj.org/toc/2096-5540 Journal toc kostenfrei https://doaj.org/toc/2641-8746 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 AR 4 2021 1 10-15 |
allfields_unstemmed |
10.1097/JD9.0000000000000151 doi (DE-627)DOAJ072984511 (DE-599)DOAJ91e0e1767fea40b0ab30a0b7032d7d00 DE-627 ger DE-627 rakwb eng RL1-803 The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine verfasserin aut Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)# 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract. Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients. The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on vitiligo in the past 3 years in combination with the clinical experiences of experts. The newly revised points include maintenance therapy, early glucocorticoid intervention, and oral mini-pulsed glucocorticoid administration protocols. The prospect of using JAK inhibitors in the treatment of vitiligo is also discussed. Dermatology Tie-Chi Lei verfasserin aut Ai-E Xu verfasserin aut Tian-Wen Gao verfasserin aut Li He verfasserin aut Hua Gu verfasserin aut Ming Li verfasserin aut Tie-Nan Li verfasserin aut Chun-Ying Li verfasserin aut Tong Lin verfasserin aut Kuan-Hou Mu verfasserin aut Chai-Xia Tu verfasserin aut Hai Wen verfasserin aut Ji-Yuan Wu verfasserin aut Jun-Ling Zhang verfasserin aut Zhi-Zhong Zhen verfasserin aut In International Journal of Dermatology and Venerology Wolters Kluwer Health, 2020 4(2021), 1, Seite 10-15 (DE-627)1738992934 26418746 nnns volume:4 year:2021 number:1 pages:10-15 https://doi.org/10.1097/JD9.0000000000000151 kostenfrei https://doaj.org/article/91e0e1767fea40b0ab30a0b7032d7d00 kostenfrei http://journals.lww.com/10.1097/JD9.0000000000000151 kostenfrei https://doaj.org/toc/2096-5540 Journal toc kostenfrei https://doaj.org/toc/2641-8746 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 AR 4 2021 1 10-15 |
allfieldsGer |
10.1097/JD9.0000000000000151 doi (DE-627)DOAJ072984511 (DE-599)DOAJ91e0e1767fea40b0ab30a0b7032d7d00 DE-627 ger DE-627 rakwb eng RL1-803 The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine verfasserin aut Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)# 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract. Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients. The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on vitiligo in the past 3 years in combination with the clinical experiences of experts. The newly revised points include maintenance therapy, early glucocorticoid intervention, and oral mini-pulsed glucocorticoid administration protocols. The prospect of using JAK inhibitors in the treatment of vitiligo is also discussed. Dermatology Tie-Chi Lei verfasserin aut Ai-E Xu verfasserin aut Tian-Wen Gao verfasserin aut Li He verfasserin aut Hua Gu verfasserin aut Ming Li verfasserin aut Tie-Nan Li verfasserin aut Chun-Ying Li verfasserin aut Tong Lin verfasserin aut Kuan-Hou Mu verfasserin aut Chai-Xia Tu verfasserin aut Hai Wen verfasserin aut Ji-Yuan Wu verfasserin aut Jun-Ling Zhang verfasserin aut Zhi-Zhong Zhen verfasserin aut In International Journal of Dermatology and Venerology Wolters Kluwer Health, 2020 4(2021), 1, Seite 10-15 (DE-627)1738992934 26418746 nnns volume:4 year:2021 number:1 pages:10-15 https://doi.org/10.1097/JD9.0000000000000151 kostenfrei https://doaj.org/article/91e0e1767fea40b0ab30a0b7032d7d00 kostenfrei http://journals.lww.com/10.1097/JD9.0000000000000151 kostenfrei https://doaj.org/toc/2096-5540 Journal toc kostenfrei https://doaj.org/toc/2641-8746 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 AR 4 2021 1 10-15 |
allfieldsSound |
10.1097/JD9.0000000000000151 doi (DE-627)DOAJ072984511 (DE-599)DOAJ91e0e1767fea40b0ab30a0b7032d7d00 DE-627 ger DE-627 rakwb eng RL1-803 The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine verfasserin aut Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)# 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract. Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients. The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on vitiligo in the past 3 years in combination with the clinical experiences of experts. The newly revised points include maintenance therapy, early glucocorticoid intervention, and oral mini-pulsed glucocorticoid administration protocols. The prospect of using JAK inhibitors in the treatment of vitiligo is also discussed. Dermatology Tie-Chi Lei verfasserin aut Ai-E Xu verfasserin aut Tian-Wen Gao verfasserin aut Li He verfasserin aut Hua Gu verfasserin aut Ming Li verfasserin aut Tie-Nan Li verfasserin aut Chun-Ying Li verfasserin aut Tong Lin verfasserin aut Kuan-Hou Mu verfasserin aut Chai-Xia Tu verfasserin aut Hai Wen verfasserin aut Ji-Yuan Wu verfasserin aut Jun-Ling Zhang verfasserin aut Zhi-Zhong Zhen verfasserin aut In International Journal of Dermatology and Venerology Wolters Kluwer Health, 2020 4(2021), 1, Seite 10-15 (DE-627)1738992934 26418746 nnns volume:4 year:2021 number:1 pages:10-15 https://doi.org/10.1097/JD9.0000000000000151 kostenfrei https://doaj.org/article/91e0e1767fea40b0ab30a0b7032d7d00 kostenfrei http://journals.lww.com/10.1097/JD9.0000000000000151 kostenfrei https://doaj.org/toc/2096-5540 Journal toc kostenfrei https://doaj.org/toc/2641-8746 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 AR 4 2021 1 10-15 |
language |
English |
source |
In International Journal of Dermatology and Venerology 4(2021), 1, Seite 10-15 volume:4 year:2021 number:1 pages:10-15 |
sourceStr |
In International Journal of Dermatology and Venerology 4(2021), 1, Seite 10-15 volume:4 year:2021 number:1 pages:10-15 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Dermatology |
isfreeaccess_bool |
true |
container_title |
International Journal of Dermatology and Venerology |
authorswithroles_txt_mv |
The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine @@aut@@ Tie-Chi Lei @@aut@@ Ai-E Xu @@aut@@ Tian-Wen Gao @@aut@@ Li He @@aut@@ Hua Gu @@aut@@ Ming Li @@aut@@ Tie-Nan Li @@aut@@ Chun-Ying Li @@aut@@ Tong Lin @@aut@@ Kuan-Hou Mu @@aut@@ Chai-Xia Tu @@aut@@ Hai Wen @@aut@@ Ji-Yuan Wu @@aut@@ Jun-Ling Zhang @@aut@@ Zhi-Zhong Zhen @@aut@@ |
publishDateDaySort_date |
2021-01-01T00:00:00Z |
hierarchy_top_id |
1738992934 |
id |
DOAJ072984511 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ072984511</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309112723.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1097/JD9.0000000000000151</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ072984511</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ91e0e1767fea40b0ab30a0b7032d7d00</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RL1-803</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)#</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract. Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients. The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on vitiligo in the past 3 years in combination with the clinical experiences of experts. The newly revised points include maintenance therapy, early glucocorticoid intervention, and oral mini-pulsed glucocorticoid administration protocols. The prospect of using JAK inhibitors in the treatment of vitiligo is also discussed.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Dermatology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tie-Chi Lei</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ai-E Xu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tian-Wen Gao</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li He</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hua Gu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ming Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tie-Nan Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Chun-Ying Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tong Lin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kuan-Hou Mu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Chai-Xia Tu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hai Wen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ji-Yuan Wu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jun-Ling Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhi-Zhong Zhen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International Journal of Dermatology and Venerology</subfield><subfield code="d">Wolters Kluwer Health, 2020</subfield><subfield code="g">4(2021), 1, Seite 10-15</subfield><subfield code="w">(DE-627)1738992934</subfield><subfield code="x">26418746</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:10-15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1097/JD9.0000000000000151</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/91e0e1767fea40b0ab30a0b7032d7d00</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://journals.lww.com/10.1097/JD9.0000000000000151</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2096-5540</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2641-8746</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">2021</subfield><subfield code="e">1</subfield><subfield code="h">10-15</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine |
spellingShingle |
The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine misc RL1-803 misc Dermatology Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)# |
authorStr |
The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)1738992934 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RL1-803 |
illustrated |
Not Illustrated |
issn |
26418746 |
topic_title |
RL1-803 Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)# |
topic |
misc RL1-803 misc Dermatology |
topic_unstemmed |
misc RL1-803 misc Dermatology |
topic_browse |
misc RL1-803 misc Dermatology |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
International Journal of Dermatology and Venerology |
hierarchy_parent_id |
1738992934 |
hierarchy_top_title |
International Journal of Dermatology and Venerology |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)1738992934 |
title |
Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)# |
ctrlnum |
(DE-627)DOAJ072984511 (DE-599)DOAJ91e0e1767fea40b0ab30a0b7032d7d00 |
title_full |
Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)# |
author_sort |
The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine |
journal |
International Journal of Dermatology and Venerology |
journalStr |
International Journal of Dermatology and Venerology |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2021 |
contenttype_str_mv |
txt |
container_start_page |
10 |
author_browse |
The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine Tie-Chi Lei Ai-E Xu Tian-Wen Gao Li He Hua Gu Ming Li Tie-Nan Li Chun-Ying Li Tong Lin Kuan-Hou Mu Chai-Xia Tu Hai Wen Ji-Yuan Wu Jun-Ling Zhang Zhi-Zhong Zhen |
container_volume |
4 |
class |
RL1-803 |
format_se |
Elektronische Aufsätze |
author-letter |
The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine |
doi_str_mv |
10.1097/JD9.0000000000000151 |
author2-role |
verfasserin |
title_sort |
consensus on the diagnosis and treatment of vitiligo in china (2021 revision)# |
callnumber |
RL1-803 |
title_auth |
Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)# |
abstract |
Abstract. Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients. The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on vitiligo in the past 3 years in combination with the clinical experiences of experts. The newly revised points include maintenance therapy, early glucocorticoid intervention, and oral mini-pulsed glucocorticoid administration protocols. The prospect of using JAK inhibitors in the treatment of vitiligo is also discussed. |
abstractGer |
Abstract. Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients. The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on vitiligo in the past 3 years in combination with the clinical experiences of experts. The newly revised points include maintenance therapy, early glucocorticoid intervention, and oral mini-pulsed glucocorticoid administration protocols. The prospect of using JAK inhibitors in the treatment of vitiligo is also discussed. |
abstract_unstemmed |
Abstract. Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients. The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on vitiligo in the past 3 years in combination with the clinical experiences of experts. The newly revised points include maintenance therapy, early glucocorticoid intervention, and oral mini-pulsed glucocorticoid administration protocols. The prospect of using JAK inhibitors in the treatment of vitiligo is also discussed. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 |
container_issue |
1 |
title_short |
Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)# |
url |
https://doi.org/10.1097/JD9.0000000000000151 https://doaj.org/article/91e0e1767fea40b0ab30a0b7032d7d00 http://journals.lww.com/10.1097/JD9.0000000000000151 https://doaj.org/toc/2096-5540 https://doaj.org/toc/2641-8746 |
remote_bool |
true |
author2 |
Tie-Chi Lei Ai-E Xu Tian-Wen Gao Li He Hua Gu Ming Li Tie-Nan Li Chun-Ying Li Tong Lin Kuan-Hou Mu Chai-Xia Tu Hai Wen Ji-Yuan Wu Jun-Ling Zhang Zhi-Zhong Zhen |
author2Str |
Tie-Chi Lei Ai-E Xu Tian-Wen Gao Li He Hua Gu Ming Li Tie-Nan Li Chun-Ying Li Tong Lin Kuan-Hou Mu Chai-Xia Tu Hai Wen Ji-Yuan Wu Jun-Ling Zhang Zhi-Zhong Zhen |
ppnlink |
1738992934 |
callnumber-subject |
RL - Dermatology |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1097/JD9.0000000000000151 |
callnumber-a |
RL1-803 |
up_date |
2024-07-03T15:10:54.582Z |
_version_ |
1803571119610920960 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ072984511</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309112723.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1097/JD9.0000000000000151</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ072984511</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ91e0e1767fea40b0ab30a0b7032d7d00</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RL1-803</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">The Vitiligo Expert Group of the Dermatovenereology Professional Committee, Chinese Society of Integrated Chinese and Western Medicine</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)#</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract. Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients. The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on vitiligo in the past 3 years in combination with the clinical experiences of experts. The newly revised points include maintenance therapy, early glucocorticoid intervention, and oral mini-pulsed glucocorticoid administration protocols. The prospect of using JAK inhibitors in the treatment of vitiligo is also discussed.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Dermatology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tie-Chi Lei</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ai-E Xu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tian-Wen Gao</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li He</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hua Gu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ming Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tie-Nan Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Chun-Ying Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tong Lin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kuan-Hou Mu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Chai-Xia Tu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hai Wen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ji-Yuan Wu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jun-Ling Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhi-Zhong Zhen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International Journal of Dermatology and Venerology</subfield><subfield code="d">Wolters Kluwer Health, 2020</subfield><subfield code="g">4(2021), 1, Seite 10-15</subfield><subfield code="w">(DE-627)1738992934</subfield><subfield code="x">26418746</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:10-15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1097/JD9.0000000000000151</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/91e0e1767fea40b0ab30a0b7032d7d00</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://journals.lww.com/10.1097/JD9.0000000000000151</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2096-5540</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2641-8746</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">2021</subfield><subfield code="e">1</subfield><subfield code="h">10-15</subfield></datafield></record></collection>
|
score |
7.399806 |